Market Place
Sourcing Support
Pharma Companies Rush to Develop Weight-loss Drug Semaglutide
12 Apr 2025 //
ECONOMICTIMES
OneSource pharma gets ANVISA GMP for Bengaluru unit 2
10 Apr 2025 //
EXPRESSPHARMA
India`s anti-obesity drug market quadruples in 5 years
08 Apr 2025 //
ECONOMICTIMES
Novo Nordisk readies to bring weight-loss drug Wegovy to India
07 Apr 2025 //
ECONOMICTIMES
Novo nearly doubles earnings as Wegovy swells coffers
03 Apr 2025 //
REUTERS
Ozempic® 1 mg improves outcomes in type 2 diabetes & PAD at Meeting
29 Mar 2025 //
PR NEWSWIRE
Ozempic improves walking distance in adults with type 2 diabetes
29 Mar 2025 //
GLOBENEWSWIRE
Novo Nordisk: Rybelsus shows superior cardiovascular event reduct
29 Mar 2025 //
GLOBENEWSWIRE
CPC: Semaglutide Improves Walking Distance for PAD, Diabetes
29 Mar 2025 //
ACCESSWIRE
Novo to license obesity drug from Lexicon in up to $1 B deal
29 Mar 2025 //
FIERCE BIOTECH
Vivani Medical: Positive Preclinical Weight Loss Data for NPM-139
26 Mar 2025 //
GLOBENEWSWIRE
Novo offers cheaper Wegovy for all cash-paying patients
25 Mar 2025 //
FIERCE PHARMA
Brazil`s Hypera to launch an Ozempic generic in 2026
22 Mar 2025 //
REUTERS
Novo presents new semaglutide data at ACC 74th Scientific Sessions
17 Mar 2025 //
PR NEWSWIRE
CVS Weight Management Program Boosts Health, Cuts Costs
14 Mar 2025 //
PR NEWSWIRE
PatchMD Launches GLP-1 Support Patches For Weight Loss Patients
12 Mar 2025 //
GLOBENEWSWIRE
FDA to hold off action on weight-loss drug copies pending court ruling
11 Mar 2025 //
REUTERS
Novo trial with next-gen diabetes drug shows 15.7% weight loss
10 Mar 2025 //
REUTERS
Novo to sell Wegovy for $499 a month to cash-paying US customers
06 Mar 2025 //
PR NEWSWIRE
Novo Nordisk Launches "My Ozempic Era" Campaign For Patients
03 Mar 2025 //
PR NEWSWIRE
Lilly offers weight-loss drugs in vials at a discount
27 Feb 2025 //
PRESS RELEASE
Novo`s Wegovy and Ozempic removed from US FDA shortage list
22 Feb 2025 //
REUTERS
FDA Confirms Wegovy & Ozempic Shortage Over, Novo Meets Demand
21 Feb 2025 //
PR NEWSWIRE
Rani Therapeutics Announces Preclinical Data on Semaglutide
05 Feb 2025 //
GLOBENEWSWIRE
Wegovy maker Novo says surging growth driving emissions higher
05 Feb 2025 //
REUTERS
FDA approves Novo`s Ozempic to cut risk of diabetic kidney disease
29 Jan 2025 //
PRESS RELEASE
Veru`s drug helps older obese patients on Wegovy preserve muscle
28 Jan 2025 //
REUTERS
Study of Novo, Lilly weight loss drugs show decrease in Alzheimer`s
22 Jan 2025 //
FIERCE PHARMA
Novo touts weight loss results in high-dose Wegovy study
18 Jan 2025 //
FIERCE PHARMA
Novo`s Ozempic, Wegovy picked for US Medicare price negotiations
18 Jan 2025 //
REUTERS
Novo Nordisk: Semaglutide Shows 20.7% Weight Loss In Step up Trial
17 Jan 2025 //
GLOBENEWSWIRE
Wegovy and Zepbound tipped to fuel $20B heart failure boom
08 Jan 2025 //
FIERCE PHARMA
Found Offers Affordable Needle-Free Semaglutide For Weight Care
08 Jan 2025 //
BUSINESSWIRE
SomaScan Assay Drives Insights On Semaglutide Published In Nature
08 Jan 2025 //
GLOBENEWSWIRE
Biomea Reports Preclinical Data On Icovamenib-Semaglutide Study
07 Jan 2025 //
GLOBENEWSWIRE
Eden Unveils the World`s First Compounded GLP-1 Rx Gummy
31 Dec 2024 //
PR NEWSWIRE
Novo stock crashes after CagriSema misses weight-loss goal
21 Dec 2024 //
FIERCE BIOTECH
Diabetes Brands Dexcom, Ozempic, Mounjaro Drive Q3 Ad Engagement
19 Dec 2024 //
BUSINESSWIRE
TNF Pharma Launches Trial on Lead Candidate in Sarcopenia/Frailty
19 Dec 2024 //
BUSINESSWIRE
Ascletis Announces ASC47 for Obesity with Superior Weight Loss
18 Dec 2024 //
PR NEWSWIRE
Novo Nordisk`s Ozempic faces EU review for potential eye disease connection
18 Dec 2024 //
REUTERS
FDA warns online vendors selling unapproved weight-loss drugs
18 Dec 2024 //
REUTERS
Novo`s Ozempic faces scrutiny over potential link to rare eye disease
17 Dec 2024 //
REUTERS
Novo Nordisk Snags Kidney Disease Expansion for Ozempic in Europe
14 Dec 2024 //
BIOSPACE
Cellev8 Nutrition Launches First GLP1 Support Gummy
12 Dec 2024 //
ACCESSWIRE
PeptiDream Shows Oral Myostatin Inhibitors Prevent Lean Mass Loss
12 Dec 2024 //
BUSINESSWIRE
FDA chief Defends Obesity Work Before Senate RFK Jr Criticism
06 Dec 2024 //
REUTERS
Lilly`s Zepbound Beats Wegovy In Weight Loss Trial: 20.2% Vs. 13.7%
05 Dec 2024 //
PR NEWSWIRE
Novo India execs urge early Wegovy launch as weight-loss rival
03 Dec 2024 //
ECONOMICTIMES
BioNxt Solutions Develops Sublingual Thin-Film for Semaglutide
02 Dec 2024 //
ACCESSWIRE
ProLynx Publishes Once Monthly Semaglutide in PNAS
02 Dec 2024 //
PR NEWSWIRE
Novo Nordisk launches obesity drug Wegovy in China
19 Nov 2024 //
REUTERS
Helix Introduces Precision Model for Semaglutide Weight Loss
13 Nov 2024 //
PR NEWSWIRE
US Minority Veterans Face Unequal Access to Ozempic, Wegovy
11 Nov 2024 //
REUTERS
Novo expects high demand for its obesity drugs in India
07 Nov 2024 //
REUTERS
Novo reports mixed sales on GLP-1 stalwarts Ozempic, Wegovy
06 Nov 2024 //
FIERCE PHARMA
Novo affirms 25% weight-loss for experimental drug CagriSema
06 Nov 2024 //
REUTERS
Novo`s Wegovy weight-loss drug sales beat forecast, shares jump
06 Nov 2024 //
REUTERS
Select Trial: Semaglutide Reduces Hospital Admissions in Obesity
03 Nov 2024 //
PR NEWSWIRE
FDA expunges all Ozempic, Wegovy doses from shortage list
02 Nov 2024 //
FIERCE PHARMA
